257 related articles for article (PubMed ID: 18539355)
1. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance.
Lee ES; Gao Z; Kim D; Park K; Kwon IC; Bae YH
J Control Release; 2008 Aug; 129(3):228-36. PubMed ID: 18539355
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
Kim D; Lee ES; Park K; Kwon IC; Bae YH
Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer.
Kim D; Gao ZG; Lee ES; Bae YH
Mol Pharm; 2009; 6(5):1353-62. PubMed ID: 19507896
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.
Kim D; Lee ES; Oh KT; Gao ZG; Bae YH
Small; 2008 Nov; 4(11):2043-50. PubMed ID: 18949788
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
Gao ZG; Lee DH; Kim DI; Bae YH
J Drug Target; 2005 Aug; 13(7):391-7. PubMed ID: 16308207
[TBL] [Abstract][Full Text] [Related]
7. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model.
Jin ZH; Jin MJ; Jiang CG; Yin XZ; Jin SX; Quan XQ; Gao ZG
Acta Pharmacol Sin; 2014 Jun; 35(6):839-45. PubMed ID: 24902790
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
[TBL] [Abstract][Full Text] [Related]
12. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles.
Gao ZG; Tian L; Hu J; Park IS; Bae YH
J Control Release; 2011 May; 152(1):84-9. PubMed ID: 21295088
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
[TBL] [Abstract][Full Text] [Related]
14. Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.
Zhang CG; Zhu WJ; Liu Y; Yuan ZQ; Yang SD; Chen WL; Li JZ; Zhou XF; Liu C; Zhang XN
Sci Rep; 2016 Mar; 6():23859. PubMed ID: 27030638
[TBL] [Abstract][Full Text] [Related]
15. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
[TBL] [Abstract][Full Text] [Related]
16. Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells.
Mohajer G; Lee ES; Bae YH
Pharm Res; 2007 Sep; 24(9):1618-27. PubMed ID: 17385015
[TBL] [Abstract][Full Text] [Related]
17. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
[TBL] [Abstract][Full Text] [Related]
18. L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity.
Oh KT; Lee ES; Kim D; Bae YH
Int J Pharm; 2008 Jun; 358(1-2):177-83. PubMed ID: 18407443
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin.
Qin L; Wu L; Jiang S; Yang D; He H; Zhang F; Zhang P
J Drug Target; 2018 Apr; 26(4):289-295. PubMed ID: 28901798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
